$CARE

Carter Bankshares, Inc. Announces Third Quarter 2026 Financial Results

Carter Bankshares, Inc. (CARE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE – October 29, 2026 Carter Bankshares, Inc. Announces Third Quarter 2026 Financial Results Martinsville, VA, October 29, 2026 – Carter Bankshares, Inc. (the “Company”) (NASDAQ:CARE), the holding company of Carter Bank (the “Bank”) today announced

Original reporting
Published Oct 29, 2026, 12:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 12:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CARE
Neutral
high confidence
Mentioned
$CARE
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CARENeutralMed
01

Why it matters

The release provides fresh earnings data and a new capital‑return mechanism, offering traders fresh information to assess valuation.

02

Market read

Primary earnings disclosure for a U.S. listed regional bank; relevant for investors in financial sector.

03

What to watch

Impact of recent loan sale and insurance transaction gains may mask underlying credit quality concerns.

Relevance 7/10Novelty 7/10Timing: post-market release

Background

Carter Bankshares filed a Form 8‑K reporting its Q3 2026 financial results and launch of a dividend reinvestment and stock purchase plan.

Company-level read

Ticker impact

$CARENeutralHigh confidence
Context

Q3 2026 earnings released with net income $7.8M, EPS $0.35 and new dividend reinvestment plan.

Expected impact

potential modest upside as market prices in earnings beat and new capital plan

Evidence & confidence

First report of quarterly results with better-than-previous quarter metrics and a shareholder-friendly program.

Market effects

May signal strength in regional banking sector and could influence peer valuations.

Limited to U.S. regional banks; no broad market effect.

Low

Counterpoint

Earnings growth may be unsustainable given higher loan payoffs and modest net interest margin expansion.

Key entities

  • Carter Bankshares, Inc.

    Regional bank reporting Q3 results and DRIP launch.

Related articles

$CAREMedAI 8/10

Carter Bankshares Reports Q3 Net Income of $7.8 Million, NIM of 3.55%

Carter Bankshares reported Q3 2026 net income of $7.8M ($0.35 per diluted share), with adjusted net income at $7.6M. Net interest income rose $1.3M QoQ to $41.2M, and net interest margin increased to 3.55%. Portfolio loans grew $36M sequentially, while nonperforming loans fell to 0.74%. The company maintains strong capital and liquidity, with a 14.24% CET1 ratio and $1.6B in available liquidity.

$CAREMed

Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results

Carter Bankshares, Inc. (CARE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 care-2q26_ex991xer.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE – July 23, 2026 Carter Bankshares, Inc. Announces Second Quarter 2026 Financial Results Martinsville, VA, July 23, 2026 – Carter Bankshares, Inc. (the “Company”) (NASDAQ:CARE), the holding compan

$EXPDMed

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD): Results of Operations and Financial Condition

EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 EARNINGS RELEASE By: Expeditors International of Washington, Inc. 3545 Factoria Blvd. SE Sterling Plaza 2, 3rd Floor Bellevue, Washington 98006 CONTACTS : Daniel R. Wall David A. Hackett Geoffrey Buscher President and Chief Executive Officer Senior Vice President and

$HSICMedAI 8/10

Henry Schein, Inc. Q3 2026 Earnings Call Summary

Henry Schein reported Q3 2026 US dental merchandise growth of 8.6%, driven by volume. The company targets $200M in operating income improvements by 2026, with $125M expected by year-end. Non-GAAP EPS guidance raised to $5.50–$5.56. Management expects double-digit EPS growth in 2027, supported by value creation initiatives and portfolio shifts. Q3 included a $0.19 per share tariff refund benefit and $22M in restructuring expenses. Emmanuel Capre will succeed Ronald South as CFO in November 2026.